TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $108,000 | +125.0% | 3,400 | +88.9% | 0.01% | +133.3% |
| Q1 2022 | $48,000 | -28.4% | 1,800 | -10.0% | 0.00% | 0.0% |
| Q4 2021 | $67,000 | -51.8% | 2,000 | -4.8% | 0.00% | -50.0% |
| Q3 2021 | $139,000 | -14.7% | 2,100 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $163,000 | – | 2,100 | -60.4% | 0.01% | – |
| Q1 2021 | $0 | -100.0% | 5,300 | +1666.7% | 0.00% | – |
| Q4 2020 | $6,000 | -76.9% | 300 | -50.0% | 0.00% | -100.0% |
| Q1 2020 | $26,000 | -29.7% | 600 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $37,000 | +428.6% | 600 | +100.0% | 0.00% | +100.0% |
| Q3 2019 | $7,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |